ASPG1 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Basics and Applications

Antibodies are Y-shaped proteins produced by the immune system to recognize and neutralize antigens. They are critical tools in research, diagnostics, and therapeutics . Key applications include:

  • Diagnostics: Detection of disease-specific biomarkers (e.g., anti-D1 β2GPI antibodies in antiphospholipid syndrome) .

  • Therapeutics: Engineered antibodies for cancer immunotherapy (e.g., anti-PD-1/PD-L1 antibodies) .

  • Research: Blocking protein-protein interactions or probing intracellular pathways (e.g., scFvs in GPCR signaling) .

Challenges in Antibody Development for Membrane-Bound Targets

Antibodies targeting membrane-bound receptors, such as ASGR1 (asialoglycoprotein receptor 1), face challenges due to high antigen density and rapid recycling. For example:

  • ASGR1 has ~1 million copies per hepatocyte, leading to rapid antibody depletion in vivo .

  • pH/Ca²⁺-dependent "catch-and-release" antibodies showed no improvement in serum exposure for ASGR1, contrary to expectations .

Key Features of Recombinant Antibodies

Recombinant antibodies offer advantages in specificity and engineering:

FeatureApplication
pH-dependent bindingReduces target-mediated drug disposition (TMDD)
FcRn affinity engineeringProlongs serum half-life
Single-chain variable fragments (scFvs)Intracellular signaling studies

Antibody Validation and Specificity

Rigorous validation is essential for reliability:

  • Protein arrays: Used to confirm specificity (e.g., Human Protein Atlas) .

  • Immunohistochemistry/Western blot: Standard techniques for localization and expression analysis .

  • Functional assays: Neutralization or receptor-binding studies (e.g., ACE2 inhibition by SP1-77 antibody) .

Potential Research Directions for ASPG1 Antibodies

While no ASPG1-specific antibody data exists, lessons from related studies suggest:

  • Target prioritization: ASPG1’s role in drought resistance in plants could inspire analogous studies in stress-response pathways in other organisms.

  • Antibody engineering: pH-sensitive or FcRn-enhanced designs might improve efficacy if ASPG1 is membrane-bound .

Limitations and Gaps

  • No mammalian ASPG1 homolog: Current literature describes ASPG1 exclusively in Arabidopsis, limiting direct antibody applications .

  • Commercial availability: Antibodies for similarly named targets (e.g., ASPSCR1) exist but are unrelated .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ASPG1 antibody; At3g18490 antibody; MYF24.22Protein ASPARTIC PROTEASE IN GUARD CELL 1 antibody; AtASPG1 antibody; EC 3.4.23.- antibody
Target Names
ASPG1
Uniprot No.

Target Background

Function
ASPG1 is an aspartic protease that plays a crucial role in drought avoidance through abscisic acid signaling.
Gene References Into Functions
  1. ASPG1 is essential for seed dormancy, seed longevity, and seed germination. Its function is linked to the degradation of seed storage proteins and the regulation of gibberellic acid signaling in Arabidopsis. PMID: 29648652
  2. Overexpression of the ASPG1 (AT3G18490) gene confers drought avoidance. PMID: 22268147
Database Links

KEGG: ath:AT3G18490

STRING: 3702.AT3G18490.1

UniGene: At.22647

Protein Families
Peptidase A1 family
Subcellular Location
Endoplasmic reticulum.
Tissue Specificity
Expressed in young seedlings, leaves, guard-cells, stems, flowers and siliques, but not in roots or mesophyll cells.

Q&A

What is ASPG1 and what research applications are ASPG1 antibodies validated for?

ASPG1 (Aspartic Protease Gene 1) is a protein found in Arabidopsis thaliana (Mouse-ear cress), an important model organism in plant biology research. According to the product information, commercially available ASPG1 antibodies have been validated specifically for ELISA and Western Blotting applications .

The antibody is typically raised in rabbits using recombinant Arabidopsis thaliana ASPG1 protein as the immunogen, making it highly specific for plant research applications. The polyclonal nature of these antibodies enables detection of multiple epitopes within the target protein, potentially increasing sensitivity compared to monoclonal alternatives.

For research planning purposes, it's important to note that ASPG1 antibodies should be considered research-use-only tools, and are not validated for diagnostic or therapeutic applications .

What are the optimal storage and handling conditions for maintaining ASPG1 antibody activity?

To maintain optimal antibody performance, ASPG1 antibodies require specific storage and handling protocols:

  • Upon receipt, store immediately at -20°C or -80°C for long-term stability

  • Avoid repeated freeze-thaw cycles which can degrade antibody performance

  • The antibody is typically supplied in a protective buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative

  • When preparing working dilutions, use fresh aliquots whenever possible

These storage requirements are consistent with best practices for maintaining antibody stability and functionality in research settings. Proper storage is particularly important for antibodies used in quantitative applications where consistency between experiments is critical.

How can I validate ASPG1 antibody specificity in plant tissue samples?

Validating antibody specificity is crucial for generating reliable research data. For ASPG1 antibodies, consider implementing this comprehensive validation protocol:

  • Western blot analysis: Confirm detection of a single band at the expected molecular weight of ASPG1

  • Genetic validation: Compare signal between wild-type and ASPG1 knockout/knockdown plant lines

  • Epitope competition: Pre-incubate antibody with excess immunizing peptide before application

  • Cross-species reactivity assessment: Test antibody against related plant species with varying degrees of ASPG1 homology

This multi-method approach resembles validation strategies used for other plant antibodies and follows principles similar to those applied in rational antibody design targeting specific epitopes .

What controls should be included when using ASPG1 antibody in experimental protocols?

Incorporating appropriate controls is essential for generating interpretable data with ASPG1 antibodies:

Table 1: Essential Controls for ASPG1 Antibody Experiments

Control TypeImplementationPurposeCritical Considerations
Positive controlRecombinant ASPG1 protein or extract from tissues known to express ASPG1Confirms antibody functionalityUse consistent positive control across experiments
Negative controlExtract from ASPG1 knockout plants or non-plant samplesValidates specificityMatch sample preparation method with experimental samples
Technical controlsSecondary antibody only (omit primary)Identifies non-specific bindingInclude in every experiment
Peptide competitionPre-incubate with immunizing peptideConfirms epitope specificityRequires access to original immunogen
Loading controlsAntibodies against housekeeping proteins (actin, tubulin)Normalizes for loading differencesSelect appropriate loading control for tissue type

These controls represent best practices in antibody-based research and help distinguish specific signal from technical artifacts. Similar control strategies are essential for experiments with antibodies targeting specific epitopes in intrinsically disordered proteins .

How can ASPG1 antibodies be adapted for immunoprecipitation studies to identify protein interaction partners?

While not explicitly validated for immunoprecipitation in product documentation, polyclonal ASPG1 antibodies can potentially be optimized for co-immunoprecipitation (Co-IP) studies following these methodological guidelines:

  • Buffer optimization:

    • Use mild, non-denaturing lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40)

    • Include protease inhibitor cocktail to prevent degradation

    • Add phosphatase inhibitors if studying phosphorylation-dependent interactions

  • Antibody coupling:

    • Pre-clear lysates with Protein A/G beads before antibody addition

    • Use 2-5 μg antibody per 1 mg of total protein

    • Consider crosslinking antibody to beads to prevent antibody contamination in eluates

  • Validation approaches:

    • Perform reciprocal Co-IPs when possible

    • Include IgG-only controls to identify non-specific binding

    • Validate interactions through orthogonal methods (Y2H, BiFC)

This approach draws on principles similar to those used for immunoprecipitation studies with other antibodies in plant research and could be adapted for studying ASPG1 interactions in Arabidopsis.

What strategies can improve detection sensitivity when working with low-abundance ASPG1 in plant tissues?

When ASPG1 is expressed at low levels, these methodological refinements can enhance detection sensitivity:

  • Sample enrichment techniques:

    • Perform subcellular fractionation to concentrate compartments where ASPG1 is localized

    • Use ammonium sulfate precipitation to concentrate proteins before analysis

    • Consider immunoaffinity purification using the ASPG1 antibody

  • Signal amplification methods:

    • Employ tyramide signal amplification (TSA) for immunohistochemistry

    • Use high-sensitivity ECL substrates for Western blotting

    • Consider biotin-streptavidin detection systems

  • Instrumentation optimizations:

    • Use cooled CCD cameras for Western blot imaging instead of film

    • Employ confocal microscopy with spectral unmixing for immunofluorescence

    • Consider using automated imaging systems with signal enhancement algorithms

These approaches parallel techniques used for detecting other low-abundance proteins in plant systems and can be particularly valuable when studying ASPG1 under conditions where expression levels vary significantly.

How can I develop a quantitative ELISA for ASPG1 quantification in plant samples?

Developing a quantitative ELISA system requires systematic optimization of multiple parameters:

Table 2: ELISA Development Parameters for ASPG1 Quantification

ParameterOptimization RangeRecommended Starting PointValidation Metrics
Coating bufferPBS pH 7.4, Carbonate pH 9.6Carbonate buffer pH 9.6Consistent binding efficiency
Blocking agent1-5% BSA, milk, commercial blockers3% BSA in PBSSignal-to-noise ratio >10
Antibody dilution1:500-1:50001:1000Standard curve R² >0.98
Sample preparationCrude extract, purified fractionsCrude extract with detergentRecovery of spiked samples 80-120%
Detection systemColorimetric, chemiluminescentHRP/TMB colorimetricCV <15% between replicates
Dynamic range0.1-1000 ng/mL1-100 ng/mLLinear response across 2 logs

This approach follows standard practice for developing quantitative immunoassays and would enable precise measurement of ASPG1 across different experimental conditions.

How should research data be interpreted when differences in ASPG1 levels are observed between treatment conditions?

Interpreting changes in ASPG1 levels requires consideration of multiple factors:

  • Statistical validation:

    • Perform appropriate statistical tests (t-test, ANOVA) with minimum n=3 biological replicates

    • Establish significance thresholds (typically p<0.05)

    • Calculate effect sizes to determine biological relevance

  • Biological context assessment:

    • Correlate protein level changes with phenotypic observations

    • Compare with transcriptional changes using qRT-PCR

    • Consider post-translational modifications that may affect antibody recognition

  • Technical validation:

    • Confirm results with orthogonal methods (e.g., activity assays, MS-based proteomics)

    • Test for dose-response relationships when applicable

    • Consider time-course experiments to capture dynamic changes

How can ASPG1 antibodies be utilized to study protein-protein interactions in complex plant cellular environments?

Beyond basic co-immunoprecipitation, several advanced techniques can leverage ASPG1 antibodies to study protein interactions:

  • Proximity ligation assay (PLA):

    • Combines ASPG1 antibody with antibodies against suspected interaction partners

    • Oligonucleotide-conjugated secondary antibodies generate amplifiable DNA when proteins are in close proximity

    • Provides spatial information about interactions within cells

  • FRET-based approaches:

    • Primary ASPG1 antibody paired with fluorophore-conjugated secondary antibody

    • Target protein labeled with complementary fluorophore

    • Energy transfer indicates close proximity (<10 nm)

  • Crosslinking-assisted immunoprecipitation:

    • Treat samples with cell-permeable crosslinkers before lysis

    • Perform immunoprecipitation with ASPG1 antibody

    • Analyze complexes by mass spectrometry for comprehensive interaction mapping

These approaches extend beyond conventional antibody applications and enable detailed characterization of ASPG1's interaction network in plant cells.

What considerations are important when using ASPG1 antibodies to study protein modifications or processing?

Studying ASPG1 modifications requires specialized approaches beyond simple protein detection:

  • Post-translational modification analysis:

    • Immunoprecipitate ASPG1 using the antibody

    • Perform Western blot with modification-specific antibodies (phospho, ubiquitin, etc.)

    • Alternatively, analyze immunoprecipitated material by mass spectrometry

  • Proteolytic processing detection:

    • Use antibodies targeting different regions of ASPG1

    • Compare migration patterns to identify processed forms

    • Correlate processing with specific cellular conditions or treatments

  • Conformational state assessment:

    • Perform limited proteolysis before antibody detection

    • Compare native versus denatured samples

    • Use epitope-specific antibodies to detect conformational changes

This approach draws on principles similar to those employed in studying modifications of other plant proteins and could reveal important regulatory mechanisms controlling ASPG1 function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.